Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): final appraisal determination
|
Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (monotherapy): final appraisal determination
10 March 2011 (271.85 Kb 19 sec) |
This page was last updated: 08 March 2011